Augmentincont

• One study per indication was conducted (historically, two would have been required)

• NDAs were approved based on:

  • in vitro microbiology and animal work
  • PK/PD data from humans
  • one adequate, well-controlled study per indication
  • agreement to study as q12 not bid

Previous slide

Next slide

Back to first slide

View graphic version